OMIA:002421-9615 : Drug metabolism, altered in Canis lupus familiaris (dog) |
In other species: domestic cat , pig , sheep
Categories: Homeostasis / metabolism phene
Single-gene trait/disorder: unknown
Disease-related: unknown
Species summary: Martinez et al. (2024): "Greyhounds metabolize cytochrome P450 (CYP) 2B11 substrates more slowly than other dog breeds."
Molecular basis:
Martinez et al. (2020) investigatd suspected CYP2B11 deficiency in Greyhounds: "Greyhound livers metabolized CYP2B11 substrates slower, possessed lower CYP2B11 protein abundance, but had similar or higher mRNA expression than other breeds. Gene resequencing identified three CYP2B11 haplotypes, H1 (reference), H2, and H3 that were differentiated by mutations in the gene 3'-untranslated region (3'-UTR). ... Greyhounds had the highest CYP2B11-H3 allele frequency, while CYP2B11-H2 was widely distributed across most breeds. Using 3'-UTR luciferase reporter constructs, CYP2B11-H3 showed markedly lower gene expression (over 70%) compared to CYP2B11-H1 while CYP2B11-H2 expression was intermediate. Truncated mRNA transcripts were observed in CYP2B11-H2 and CYP2B11-H3 but not CYP2B11-H1 transfected cells. Our results implicate CYP2B11 3'-UTR mutations as a cause of decreased CYP2B11 enzyme expression in Greyhounds through reduced translational efficiency."
Martinez et al. (2024) identified two POR protein variants (Glu315Gln and Asp570Glu). Their "results indicate that the Glu315Gln mutation ... reduces CYP2B11 enzyme function without affecting at least one other major canine hepatic P450 (CYP2D15). Additional in vivo studies are warranted to confirm these findings."
Jaramillo et al. (2025) " describe two epileptic dogs on chronic [Phenobarbita] PB treatment that developed marked sedation and ataxia, and increased serum PB concentrations after receiving fluconazole. Both dogs were homozygous for the CYP2C41 deletion. Discontinuation of fluconazole resulted in decreased PB concentrations and resolution of clinical signs."
Breed:
Greyhound (Dog) (VBO_0200638).
Breeds in which the phene or likely causal variants have been documented. If a likely causal variant has been documented, see variant-specific breed information in the variant table. (Breed information may be incomplete).
Associated genes:
| Symbol | Description | Species | Chr | Location | OMIA gene details page | Other Links |
|---|---|---|---|---|---|---|
| POR | cytochrome p450 oxidoreductase | Canis lupus familiaris | 6 | NC_051810.1 (7068561..7137106) | POR | Ensembl, NCBI gene |
| CYP2B6 | cytochrome P450 2B11 | Canis lupus familiaris | 1 | NC_051805.1 (113415892..113431675) | CYP2B6 | Ensembl, NCBI gene |
| CYP2C41 | cytochrome P450 2C41 | Canis lupus familiaris | - | no genomic information (-..-) | CYP2C41 | Ensembl, NCBI gene |
Contact us
If you notice anything missing or in need of change, please contact us at: [email protected].
Cite this entry
Nicholas, F. W., Tammen, I., & Sydney Informatics Hub. (2025). OMIA:002421-9615: Online Mendelian Inheritance in Animals (OMIA) [dataset]. https://omia.org/. https://doi.org/10.25910/2AMR-PV70
References
Note: the references are listed in reverse chronological order (from the most recent year to the earliest year), and alphabetically by first author within a year.
| 2025 | Jaramillo, M., Mondino, A., Court, M., Lewis, M.J., Olby, N.J., Muñana, K.R. : |
| Adverse drug-drug interaction between phenobarbital and Fluconazole in two dogs. J Vet Intern Med 39:e70190, 2025. Pubmed reference: 40682369. DOI: 10.1111/jvim.70190. | |
| 2024 | Martinez, S.E., Pandey, A.V., Perez Jimenez, T.E., Zhu, Z., Court, M.H. : |
| Pharmacogenomics of poor drug metabolism in greyhounds: Canine P450 oxidoreductase genetic variation, breed heterogeneity, and functional characterization. PLoS One 19:e0297191, 2024. Pubmed reference: 38300925. DOI: 10.1371/journal.pone.0297191. | |
| Uno, Y., Shimizu, M., Yamazaki, H. : | |
| A variety of cytochrome P450 enzymes and flavin-containing monooxygenases in dogs and pigs commonly used as preclinical animal models. Biochem Pharmacol 228:116124, 2024. Pubmed reference: 38490520. DOI: 10.1016/j.bcp.2024.116124. | |
| Vaidhya, A., Ghildiyal, K., Rajawat, D., Nayak, S.S., Parida, S., Panigrahi, M. : | |
| Relevance of pharmacogenetics and pharmacogenomics in veterinary clinical practice: A review. Anim Genet 55:3-19, 2024. Pubmed reference: 37990577. DOI: 10.1111/age.13376. | |
| 2020 | Martinez, S.E., Andresen, M.C., Zhu, Z., Papageorgiou, I., Court, M.H. : |
| Pharmacogenomics of poor drug metabolism in Greyhounds: Cytochrome P450 (CYP) 2B11 genetic variation, breed distribution, and functional characterization. Sci Rep 10:69, 2020. Pubmed reference: 31919457. DOI: 10.1038/s41598-019-56660-z. | |
| 2019 | Martinez, S.E., Shi, J., Zhu, H.J., Perez Jimenez, T.E., Zhu, Z., Court, M.H. : |
| Absolute quantitation of drug-metabolizing cytochrome P450 enzymes and accessory proteins in dog liver microsomes using label-free standard-free analysis reveals interbreed variability. Drug Metab Dispos 47:1314-1324, 2019. Pubmed reference: 31427433. DOI: 10.1124/dmd.119.088070. |
Edit History
- Created by Imke Tammen2 on 07 Sep 2024
- Changed by Imke Tammen2 on 07 Sep 2024
- Changed by Imke Tammen2 on 21 Jul 2025